drugset / Trial / NCT00871182
Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of inhaled PT001 compared to placebo and tiotropium in patients with mild to moderate chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2009-03
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrrolate | Small molecule | 18 ug | Inhaled |
| Subject | Glycopyrrolate | Small molecule | 36 ug | Inhaled |
| Subject | Glycopyrrolate | Small molecule | 72 ug | Inhaled |
| Subject | Glycopyrrolate | Small molecule | 144 ug | Inhaled |
| Comparator | Tiotropium | Other / unclassified | 18 ug | — |